REGN
Price
$579.20
Change
-$7.76 (-1.32%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
61.43B
63 days until earnings call
SLXN
Price
$7.74
Change
+$0.48 (+6.61%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
5.66M
Interact to see
Advertisement

REGN vs SLXN

Header iconREGN vs SLXN Comparison
Open Charts REGN vs SLXNBanner chart's image
Regeneron Pharmaceuticals
Price$579.20
Change-$7.76 (-1.32%)
Volume$6.38K
Capitalization61.43B
Silexion Therapeutics
Price$7.74
Change+$0.48 (+6.61%)
Volume$300
Capitalization5.66M
REGN vs SLXN Comparison Chart in %
Loading...
REGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
REGN vs. SLXN commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REGN is a Buy and SLXN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (REGN: $586.96 vs. SLXN: $7.74)
Brand notoriety: REGN: Notable vs. SLXN: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: REGN: 63% vs. SLXN: 35%
Market capitalization -- REGN: $61.43B vs. SLXN: $5.66M
REGN [@Biotechnology] is valued at $61.43B. SLXN’s [@Biotechnology] market capitalization is $5.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

REGN’s FA Score shows that 1 FA rating(s) are green whileSLXN’s FA Score has 0 green FA rating(s).

  • REGN’s FA Score: 1 green, 4 red.
  • SLXN’s FA Score: 0 green, 5 red.
According to our system of comparison, REGN is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

REGN’s TA Score shows that 4 TA indicator(s) are bullish while SLXN’s TA Score has 5 bullish TA indicator(s).

  • REGN’s TA Score: 4 bullish, 4 bearish.
  • SLXN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SLXN is a better buy in the short-term than REGN.

Price Growth

REGN (@Biotechnology) experienced а -0.69% price change this week, while SLXN (@Biotechnology) price change was +13.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.10%. For the same industry, the average monthly price growth was +14.72%, and the average quarterly price growth was +30.35%.

Reported Earning Dates

REGN is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+2.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
REGN($61.4B) has a higher market cap than SLXN($5.66M). REGN YTD gains are higher at: -17.247 vs. SLXN (-74.345). REGN has higher annual earnings (EBITDA): 5.42B vs. SLXN (-17.81M). SLXN has less debt than REGN: SLXN (3.7M) vs REGN (2.71B). REGN has higher revenues than SLXN: REGN (14.2B) vs SLXN (0).
REGNSLXNREGN / SLXN
Capitalization61.4B5.66M1,084,997%
EBITDA5.42B-17.81M-30,431%
Gain YTD-17.247-74.34523%
P/E Ratio14.61N/A-
Revenue14.2B0-
Total CashN/A3.47M-
Total Debt2.71B3.7M73,148%
FUNDAMENTALS RATINGS
REGN: Fundamental Ratings
REGN
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
53
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
REGNSLXN
RSI
ODDS (%)
Bearish Trend 2 days ago
40%
Bullish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
47%
Bearish Trend 1 day ago
10%
Momentum
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 1 day ago
27%
MACD
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 1 day ago
30%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
57%
Bullish Trend 1 day ago
27%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 1 day ago
52%
Advances
ODDS (%)
Bullish Trend 8 days ago
61%
Bullish Trend 1 day ago
53%
Declines
ODDS (%)
Bearish Trend 4 days ago
54%
Bearish Trend 8 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
51%
Bullish Trend 4 days ago
38%
Aroon
ODDS (%)
Bullish Trend 2 days ago
64%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
REGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PXJ26.850.42
+1.59%
Invesco Oil & Gas Services ETF
PBAU29.000.04
+0.13%
PGIM S&P 500 Buffer 20 ETF - Aug
EIM9.810.01
+0.08%
Eaton Vance Municipal
VUSB49.920.01
+0.01%
Vanguard Ultra-Short Bond ETF
GDMA35.99-0.14
-0.37%
Gadsden Dynamic Multi-Asset ETF

REGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, REGN has been loosely correlated with ROIV. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if REGN jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REGN
1D Price
Change %
REGN100%
-0.12%
ROIV - REGN
41%
Loosely correlated
+1.27%
IDYA - REGN
40%
Loosely correlated
+0.56%
ACLX - REGN
39%
Loosely correlated
N/A
IOVA - REGN
38%
Loosely correlated
-1.22%
SMMT - REGN
38%
Loosely correlated
-8.06%
More